SI0631786T1 - Lys - plasminogen in the prevention and treatment of ischemia and reperfusian injury - Google Patents

Lys - plasminogen in the prevention and treatment of ischemia and reperfusian injury

Info

Publication number
SI0631786T1
SI0631786T1 SI9430143T SI9430143T SI0631786T1 SI 0631786 T1 SI0631786 T1 SI 0631786T1 SI 9430143 T SI9430143 T SI 9430143T SI 9430143 T SI9430143 T SI 9430143T SI 0631786 T1 SI0631786 T1 SI 0631786T1
Authority
SI
Slovenia
Prior art keywords
plasminogen
lys
ischemia
treatment
injury
Prior art date
Application number
SI9430143T
Other languages
English (en)
Slovenian (sl)
Inventor
Johann Dr. Eibl
Ludwig Prof. Pichler
Hans-Peter Schwarz
Original Assignee
Immuno Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Aktiengesellschaft filed Critical Immuno Aktiengesellschaft
Publication of SI0631786T1 publication Critical patent/SI0631786T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/484—Plasmin (3.4.21.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Electrotherapy Devices (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SI9430143T 1993-07-02 1994-07-01 Lys - plasminogen in the prevention and treatment of ischemia and reperfusian injury SI0631786T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8803393A 1993-07-02 1993-07-02
EP94110267A EP0631786B1 (en) 1993-07-02 1994-07-01 Lys - plasminogen in the prevention and treatment of ischemia and reperfusian injury

Publications (1)

Publication Number Publication Date
SI0631786T1 true SI0631786T1 (en) 1998-10-31

Family

ID=22208925

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9430143T SI0631786T1 (en) 1993-07-02 1994-07-01 Lys - plasminogen in the prevention and treatment of ischemia and reperfusian injury

Country Status (19)

Country Link
US (2) US5520912A (xx)
EP (1) EP0631786B1 (xx)
JP (1) JP2784146B2 (xx)
AT (2) AT407706B (xx)
AU (1) AU680492B2 (xx)
CA (1) CA2127199C (xx)
CZ (1) CZ283352B6 (xx)
DE (1) DE69411084T2 (xx)
DK (1) DK0631786T3 (xx)
ES (1) ES2119934T3 (xx)
GR (1) GR3027778T3 (xx)
HR (1) HRP940381B1 (xx)
HU (1) HU217961B (xx)
NO (1) NO942367L (xx)
PL (1) PL304061A1 (xx)
RU (1) RU2153353C2 (xx)
SI (1) SI0631786T1 (xx)
SK (1) SK281472B6 (xx)
ZA (1) ZA944522B (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4411143C2 (de) * 1994-03-30 1996-08-01 Immuno Ag Thrombosemittel
DE69934595T2 (de) * 1998-09-29 2007-10-04 Leuven Research & Development V.Z.W. Verwendung von verbindungen,die alpha2-antiplasmin in vivo reduzieren,zur herstellung einer zusammensetzung zur behandlung ischämischer schlaganfälle
EP1062953A1 (en) * 1999-06-22 2000-12-27 Leuven Research & Development vzw Use of compounds that reduce alpha2-antiplasmin in vivo for the preparation of a composition for the treatment of ischemic stroke
WO2000041714A1 (en) * 1999-01-19 2000-07-20 Bristol-Myers Squibb Company Method for determining care and prevention pathways for clinical management of wounds
US7184963B1 (en) 1999-01-19 2007-02-27 Bristol-Myers Squibb Company Method for determining care and prevention pathways for clinical management of wounds
WO2001058476A2 (en) * 2000-02-11 2001-08-16 The European Molecular Biology Laboratory Methods and compositions for treatment of alzheimer's disease by enhancing plasmin or plasmin-like activity
US20050124036A1 (en) * 2002-02-06 2005-06-09 Rudy Susilo Method for producing recombinant proteins in micro-organisms
CN1684706A (zh) * 2002-07-23 2005-10-19 路德维格癌症研究所 活化或抑制vegf－d和vegf－c的方法和组合物
PE20050438A1 (es) * 2003-10-20 2005-06-14 Esperion Therapeutics Inc Formulas farmaceuticas, metodos y regimenes de dosificacion para el tratamiento y la prevencion de sindromes coronarios agudos
RU2564131C2 (ru) 2009-07-10 2015-09-27 ТромбоДженикс НВ Варианты плазминогена и плазмина
US20120189609A1 (en) 2009-08-28 2012-07-26 Thrombogenics Nv Improvement to trabeculectomy
BR112013017172A2 (pt) 2011-01-05 2016-10-11 Thrombogenics Nv variantes de plasminogênio e plasmina
KR20140064841A (ko) 2011-08-12 2014-05-28 쓰롬보제닉스 엔.브이. 플라스미노겐 변이체 및 플라스민 변이체
US10531655B2 (en) 2011-12-02 2020-01-14 The Regents Of The University Of California Reperfusion protection solution and uses thereof
US11547746B2 (en) 2016-12-15 2023-01-10 Talengen International Limited Method for treating coronary atherosclerosis and complications thereof
US11389515B2 (en) 2016-12-15 2022-07-19 Talengen International Limited Method for mitigating heart disease
JP7168990B2 (ja) 2016-12-15 2022-11-10 タレンゲン インターナショナル リミテッド 肥満症を予防および治療するための方法および薬物
TW201904990A (zh) 2017-06-23 2019-02-01 美商波麥堤克生物治療股份有限公司 與pai-1過表現相關之病狀的纖維蛋白溶酶原治療
RU2729788C2 (ru) * 2018-09-04 2020-08-12 Федеральное государственное бюджетное учреждение науки "Федеральный исследовательский центр "Пущинский научный центр биологических исследований Российской академии наук" Средство, его применение и способ повышения устойчивости организма млекопитающих к ишемически-реперфузионному поражению тонкого кишечника
KR20210119428A (ko) 2019-01-24 2021-10-05 프리비파하르마, 컨설팅 게엠베하 미세혈전증의 치료 및 예방을 위한 플라스미노겐
CA3134900A1 (en) * 2019-04-12 2020-10-15 Uglk Science Ab Method and apparatus for reconditioning kidneys
CN113677200B (zh) 2019-04-12 2023-09-26 乌格勒希研究有限公司 用于修复器官的方法和装置
CN114642722A (zh) * 2020-12-18 2022-06-21 四川大学华西医院 纤溶酶原用于制备促进血管新生的药物中的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0028489B1 (en) * 1979-11-05 1983-10-05 Beecham Group Plc Enzyme derivatives, and their preparation
JP2764264B2 (ja) * 1987-10-01 1998-06-11 株式会社ミドリ十字 線溶活性増強剤
US5084274A (en) * 1987-11-17 1992-01-28 Scripps Clinic And Research Foundation Inhibition of arterial thrombotic occlusion or thromboembolism
US5256642A (en) * 1988-04-01 1993-10-26 The Johns Hopkins University Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof
AT390801B (de) * 1988-07-28 1990-07-10 Immuno Ag Verfahren zur herstellung von lys-plasminogen
US5358936A (en) * 1990-08-03 1994-10-25 Paul Gordon Anionic furanose derivatives, methods of making and using the same
AT402367B (de) * 1990-10-11 1997-04-25 Immuno Ag Pharmazeutische zubereitung auf basis von lys-plasminogen

Also Published As

Publication number Publication date
HRP940381B1 (en) 1999-06-30
HRP940381A2 (en) 1997-04-30
ES2119934T3 (es) 1998-10-16
ZA944522B (en) 1995-02-23
DE69411084T2 (de) 1998-12-03
GR3027778T3 (en) 1998-11-30
EP0631786B1 (en) 1998-06-17
NO942367L (no) 1995-01-03
AU680492B2 (en) 1997-07-31
SK79894A3 (en) 1995-05-10
US5520912A (en) 1996-05-28
EP0631786A1 (en) 1995-01-04
CA2127199C (en) 2000-11-28
SK281472B6 (sk) 2001-04-09
HU9401983D0 (en) 1994-09-28
RU94022754A (ru) 1996-08-10
JPH07145076A (ja) 1995-06-06
US5597800A (en) 1997-01-28
HUT67225A (en) 1995-03-28
HU217961B (hu) 2000-05-28
PL304061A1 (en) 1995-01-09
DK0631786T3 (da) 1999-04-06
AU6485494A (en) 1995-01-12
CZ161394A3 (en) 1995-01-18
CZ283352B6 (cs) 1998-03-18
ATA131094A (de) 2000-10-15
CA2127199A1 (en) 1995-01-03
JP2784146B2 (ja) 1998-08-06
ATE167400T1 (de) 1998-07-15
AT407706B (de) 2001-05-25
RU2153353C2 (ru) 2000-07-27
NO942367D0 (xx) 1994-06-21
DE69411084D1 (de) 1998-07-23

Similar Documents

Publication Publication Date Title
SI0631786T1 (en) Lys - plasminogen in the prevention and treatment of ischemia and reperfusian injury
GB9409281D0 (en) Transdermal device
NO885109D0 (no) FremgangsmŸte og middel for Ÿ forhindre blodpropp.
DE69432179D1 (de) Eine formulierung des gerinnungsfaktors viii
WO2002029087A3 (en) Use of lymphangiogenic agents to treat lymphatic disorders
DE60139078D1 (de) Plasminogen aktivator zur verhinderung von horn- und subepithelialeintrübung nach laser-sehkraftkorrektur-chirurgie
NZ220260A (en) Synergistic combination of t-pa and sod and pharmaceutical formulation
GR3019328T3 (en) Vampire bat salivary Plasminogen activator vPA-alpha 1
DE69832176D1 (de) Arzneimittel gegen diabetes-komplikationen
DK0604995T3 (da) Hydroxyamin-N-acylderivater, som har radikalfjernende aktivitet og kan anvendes ved akutte og kroniske patologier forbundet
RU94031618A (ru) Способ лечения кровоизлияний в мозг и устройство для его осуществления
DK0381640T3 (da) Thrombolytiske præparater
GR3005408T3 (xx)
IL130336A0 (en) Medical uses of scuPA/suPAR
Wijngaards et al. Urokinase-related fibrinolytic activity in human plasma
Zimmermann et al. Urokinase therapy of deep vein thrombosis of the lower limb
Prevot et al. Reducing “DVT hard core” through veinous stimulation report on 300 hip arthtroplasties
GABOVICH et al. STUDY OF OZONE TREATMENT OF THE DNIEPER WATER(IN RUSSIAN)
Le Querrec et al. Mode of action of aprotinin in the reduction of bleeding during orthotopic liver transplantation (OLT)
UA40717A (uk) Спосіб лікування хворих з шлунковою кровотечею